Flavonoids inhibit genetic toxicity produced by carcinogens in cells expressing CYP1A2 and CYP1A1

被引:66
|
作者
Lautraite, S
Musonda, AC
Doehmer, J
Edwards, GO
Chipman, JK [1 ]
机构
[1] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England
[2] GenPharmTox Biotech AG, D-82152 Martinsried, Germany
关键词
D O I
10.1093/mutage/17.1.45
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The effects of the flavonoids quercetin, apigenin and chrysin (10 muM) on the genetic toxicity of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and benzo[a]pyrene (BaP) was investigated at sub-cytotoxic concentrations in Chinese hamster V79 cells expressing human or rat cytochromes P450. In V79 r1A2-NH and V79 h1A1-MZ cells, none of the flavonoids increased DNA strand breaks (SB) (measured by the Comet assay) or produced detectable DNA adducts (measured by P-32-post-labelling). Neither IQ nor BaP produced DNA damage in the absence of expressed CYP1A2 or CYP1A1, respectively. DNA damage measured as SB and DNA adducts was detectable in V79 r1A2-NH cells expressing rat CYP1A2 when treated with IQ (2.5-50 muM) and this was inhibited by quercetin. Likewise, DNA damage (SB and DNA adducts) was elevated in V79 h1A1-MZ cells expressing human CYP1A1 when treated with BaP (0.1-0.5 muM) and this was inhibited by chrysin and apigenin, but not by quercetin. The specificity of CYP1A1 inhibition by chrysin and apigenin and CYP1A2 inhibition by quercetin was confirmed by ethylresorufin O-deethylase assay.
引用
收藏
页码:45 / 53
页数:9
相关论文
共 50 条
  • [31] CAR-mediated Transcriptional Activation of Human CYP1A1 and CYP1A2 Genes
    Yoshinari, Kouichi
    Yoda, Noriaki
    Yamazoe, Yasushi
    DRUG METABOLISM REVIEWS, 2009, 41 : 45 - 45
  • [32] Effect of phenobarbital on hepatic CYP1A1 and CYP1A2 in the Ahr-Null mouse
    Zaher, H
    Yang, TJ
    Gelboin, HV
    FernandezSalguero, P
    Gonzalez, FJ
    BIOCHEMICAL PHARMACOLOGY, 1998, 55 (02) : 235 - 238
  • [33] Inducibility of CYP1A2 by orneprazole in vivo related to the genetic polymorphism of CYP1A2
    Han, XM
    Ouyang, DS
    Chen, XP
    Shu, Y
    Jiang, CH
    Tan, ZR
    Zhou, HH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (05) : 540 - 543
  • [34] SYNERGISTIC INDUCTION OF RAT MICROSOMAL CYP1A1 AND CYP1A2 BY ACETONE IN COMBINATION WITH PYRIDINE
    IBA, MM
    BENNETT, S
    STORCH, A
    GHOSAL, A
    THOMAS, PE
    CANCER LETTERS, 1993, 74 (1-2) : 69 - 74
  • [35] Distinction of CYP1A1 and CYP1A2 activity by selective inhibition using fluvoxamine and isosafrole
    Pastrakuljic, A
    Tang, BK
    Roberts, EA
    Kalow, W
    BIOCHEMICAL PHARMACOLOGY, 1997, 53 (04) : 531 - 538
  • [36] CYP1A1, CYP1A2 and CYBA gene polymorphisms associated with oxidative stress in COPD
    Vibhuti, Arpana
    Arif, Ehtesham
    Mishra, Aastha
    Deepak, Desh
    Singh, Bhawani
    Rahman, Irfan
    Mohammad, Ghulam
    Pasha, M. A. Qadar
    CLINICA CHIMICA ACTA, 2010, 411 (7-8) : 474 - 480
  • [37] Induction of CYP1A1 and CYP1A2 expressions by prototypic and atypical inducers in the human lung
    Wei, C
    Caccavale, RJ
    Weyand, EH
    Chen, S
    Iba, MM
    CANCER LETTERS, 2002, 178 (01) : 25 - 36
  • [38] Constitutive and inducible levels of CYP1A1 and CYP1A2 in rat cerebral cortex and cerebellum
    Michael M. Iba
    Amijoy Storch
    Anima Ghosal
    Susan Bennett
    Kenneth R. Reuhl
    Herbert E. Lowndes
    Archives of Toxicology, 2003, 77 : 547 - 554
  • [39] Theophylline pharmacokinetics:: comparison of Cyp1a1(-/-) and Cyp1a2(-/-) knockout mice, humanized hCYP1A1_1A2 knock-in mice lacking either the mouse Cyp1a1 or Cyp1a2 gene, and Cyp1(+/+) wild-type mice
    Derkenne, S
    Curran, CP
    Shertzer, HG
    Dalton, TP
    Dragin, N
    Nebert, DW
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (07): : 503 - 511
  • [40] Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin
    Chang, Thomas K. H.
    Chen, Jie
    Yang, Guixiang
    Yeung, Eugene Y. H.
    JOURNAL OF PINEAL RESEARCH, 2010, 48 (01) : 55 - 64